The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Share News (PRTC)

Share Price Information for PureTech (PRTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 222.00
Bid: 221.50
Ask: 222.50
Change: -1.00 (-0.45%)
Spread: 1.00 (0.451%)
Open: 220.00
High: 224.00
Low: 220.00
Prev. Close: 223.00
PRTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Rockhopper loss widens; Synectics inks new contract

Thu, 28th Sep 2023 15:08

(Alliance News) - (Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Rockhopper Exploration PLC - Salisbury, England-based oil and gas exploration company - Pretax loss in the six months ended June 30 widens to USD2.6 million from USD749,000 a year prior as administrative expenses jump 40% to GBP2.1 million. Records no revenue in the half year compared to USD523,000 a year ago due to the ceasing of production. Says "the existing portfolio continues to be evaluated for further opportunities, but revenue and cost of sales are not expected to be material in the immediate future." Looking ahead, says work continues on refining a new lower cost development and financing plan for its Sea Lion project in the Falkland Islands.

----------

PureTech Health PLC - Boston-based biotechnology company - Says founded entity Karuna Therapeutics Inc submits new drug application to the US Food & Drug Administration for KarXT for the treatment of schizophrenia. Submission is sipported by efficacy and long-term safety data from a clinical program evaluating KarXT as a treatment for schizophrenia, PureTech says. In all three placebo-controlled trials, KarXT met its primary endpoint and demonstrated a "statistically significant and clinically meaningful reduction in Positive and Negative Syndrome Scale (PANSS) total score compared to placebo." As a founder of Karuna, PureTech retains an equity ownership and has rights to receive milestone payments upon the achievement of certain regulatory approvals and 20% of sublicense income. PureTech Chief Innovation Officer Eric Elenko says: "KarXT, which was invented at PureTech, showcases how we invent and advance novel medicines by giving new life to drugs that have validated pharmacology but had previously not reached patients due to an issue that is now addressable with our innovations. This NDA submission is also an important milestone for patients, as it could represent the first major advance for treating schizophrenia in over 50 years if approved by the FDA."

----------

Synectics PLC - Sheffield, England-based security and surveillance systems firm - Wins new contract with West Midlands Police for the use of its open software platform, Synergy. Has collaborated with the police force since 2005. Says additional contract will see the company integrate cameras operated by the National Highways Agency throughout the West Midlands into Synergy to increase multi-agency collaboration and improve incident response times. Chief Executive Officer Paul Webb says: "The inclusion of the regional camera network from the National Highways Agency will deliver even more comprehensive situational awareness for WMP. Integrating feeds from multiple agencies is a delicate and complex process, but with our technological expertise and compliance with protocols, we are able to deliver the end-to-end solution required by WMP."

----------

SpaceandPeople PLC - Glasgow-based retail, promotional and brand experience specialist - Subsidiary POP Retail GmbH agrees to provide retail kiosks to CEMAGG Management GmbH in its shopping centres in Germany. Chief Executive Officer Nancy Cullen says: "We are delighted to have signed this agreement with CEMAGG. It helps to further expand and consolidate our network of venues in Germany, it complements our recent agreement with Multi Germany GmbH and builds on our long-standing relationship with ECE, as well as demonstrating our focus on expanding our network of clients and venues in Europe."

----------

Atome Energy PLC - Leeds, England-based green hydrogen, ammonia, and fertilizer project development in Paraguay, Iceland, and Central America - Pretax loss in the six months ended June 30 widens to USD2.9 million from USD2.5 million a year prior, driven by a 16% increase in administrative expenses to GBP2.9m. Looking ahead, says the second half of the year is an "exciting time" for project progression, and views the outlook with "significant confidence."

----------

Cornish Metals Inc - Vancouver, Canada-based mineral exploration and development firm focused on the UK and North America - Begins wet commissioning of South Crofty mine water treatment plant in Cornwall. Says MWTP is designed to treat 25,000 metres cubed per day of water pumped directly from South Crofty mine and uses high density sludge process technology to treat raw mine water and meet the company's permitted standards for discharge into the nearby Red river. Says its project delivery team is being supported by the plant designer, equipment suppliers and contractors to "fully test and commission every aspect of the process before commencing discharge to the Red river." Expects commissioning and building of the high density sludge bed to take up to three weeks, with full dewatering of the mine anticipated to commence in October. Chief Executive Officer Richard Williams says: "The commencement of wet commissioning at the South Crofty MWTP is another exciting step towards the dewatering of South Crofty mine. Our project team, supported by a small army of dedicated local contractors, has worked extremely hard over the last 12 months to take the MWTP from a conceptual flowsheet design through to a fully constructed plant."

By Sabrina Penty, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
27 Feb 2024 11:28

PureTech notes positive results from Shionogi's EndeavorRx ADHD trial

(Alliance News) - PureTech Health PLC on Tuesday noted that its founded entity, Akili Inc, has announced positive results from a phase 3 clinical trial of EndeavorRx for children with attention deficit hyperactivity disorder in Japan.

Read more
20 Dec 2023 09:53

PureTech makes strong progress, expects "multiple catalysts" next year

(Alliance News) - PureTech Health PLC on Wednesday said it made "strong strategic and clinical progress" in 2023, and predicted "a productive and exciting" tear to come.

Read more
1 Dec 2023 14:29

TRADING UPDATES: N4 launches investor hub; Capricorn production falls

(Alliance News) - The following is a round-up of trading updates by London-listed companies, issued on Wednesday, Thursday and Friday and not separately reported by Alliance News:

Read more
17 Nov 2023 09:44

IN BRIEF: PureTech hails schizophrenia trial results for Karuna drug

PureTech Health PLC - Boston, Massachusetts-based FTSE 250 biotechnology company - Founded entity Karuna Therapeutics reports "positive results" from Phase 1b trial evaluating the effects of xanomeline-trospium, brand name KarXT, on 24-hour ambulatory blood pressure in adults with schizophrenia. Karuna says KarXT does not cause clinically meaningful blood pressure increases, with an average change from baseline at week eight of minus 0.59 mmHg or millimetre of mercury. Other vital signs like average diastolic blood pressure and heart rate were consistent with previous KarXT trials in schizophrenia. Adds that KarXT was generally well-tolerated, and side effects remained consistent with prior trials under the Emergent programme. Karuna in late September announced its application to the US Food & Drug Administration for approval of KarXT to treat schizophrenia; if successful, it will be PureTech's third therapeutic candidate to gain FDA approval. KarXT is also in development to treat psychosis associated with Alzheimer's disease.

Read more
17 Nov 2023 07:58

LONDON BRIEFING: UK retail sales fall; AstraZeneca gets US approval

(Alliance News) - Stock prices in London are still set to open higher on Friday, despite October retail sales figures for the UK disappointing shortly before the opening bell.

Read more
14 Nov 2023 10:59

PureTech Health celebrates positive results in Phase 2 anxiety trial

(Alliance News) - PureTech Health PLC on Tuesday said its therapeutic LYT-300 achieved its primary endpoint for acute anxiety reduction, in a Phase 2a trial using healthy volunteers.

Read more
11 Oct 2023 14:22

IN BRIEF: PureTech's LYT-100 shows 50% improvement to key adverse events

PureTech Health PLC - Boston-based biotechnology company - Says LYT-100 trial shows around 50% improvement in gastrointestinal and central nervous system related adverse events in adults suffering from idiopathic pulmonary fibrosis compared to US Food & Drug Administration-approved pirfenidone. Adds data shows higher dose of LYT-100 well-tolerated with no additional incidence of GI or CNS AEs when titrated up from 550 milligrams dosage.

Read more
4 Oct 2023 13:55

PureTech Health subsidiary receives fast track designation for VE202

(Alliance News) - PureTech Health PLC on Wednesday said its subsidiary Vedanta Biosciences has received fast-track designation for its VE202 treatment.

Read more
27 Sep 2023 10:40

Arix Bioscience boosts net value, CEO jumping ship for PureTech Health

(Alliance News) - Arix Bioscience PLC on Wednesday said net asset value increased in its latest half year, but has since launched a strategic review due to "unfavourable" conditions while Chief Executive Officer Robert Lyne prepares to step down.

Read more
29 Aug 2023 09:39

PureTech narrows interim loss despite "stormy market challenges"

(Alliance News) - PureTech Health PLC on Tuesday said its half-year loss narrowed, but saw its revenue fall by more than half.

Read more
29 Aug 2023 09:03

LONDON MARKET OPEN: FTSE 100 catches up with bank holiday rally

(Alliance News) - Stock prices in London opened higher on Tuesday, as UK markets return from a long bank holiday weekend and news that UK shop price inflation decelerated in August.

Read more
29 Aug 2023 07:49

LONDON BRIEFING: Bunzl profit up; Rio Tinto sells copper project stake

(Alliance News) - Stocks in London are called to open higher on Tuesday, following a long bank holiday weekend.

Read more
22 Aug 2023 15:46

UK earnings, trading statements calendar - next 7 days

Wednesday 23 August 
Angling Direct PLCTrading Statement
Costain Group PLCHalf Year Results
Thursday 24 August 
Benchmark Holdings PLCQ3 Results
CRH PLCHalf Year Results
Harbour Energy PLCHalf Year Results
Hays PLCFull Year Results
Hunting PLCHalf Year Results
James Cropper PLCHalf Year Results
Macfarlane Group PLCHalf Year Results
Princess Private Equity Holding LtdHalf Year Results
Redcentric PLCFull Year Results
South32 LtdFull Year Results
Tribal Group PLCHalf Year Results
Friday 25 August 
no events scheduled 
Monday 28 August 
no events scheduled 
Tuesday 29 August 
Amaroq Minerals LtdHalf Year Results
Bunzl PLCHalf Year Results
Dalata Hotel Group PLCHalf Year Results
Faron Pharmaceuticals LtdHalf Year Results
PureTech Health PLCHalf Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
1 Aug 2023 17:31

TRADING UPDATES: Plant Health in Poland boost; PureTech gets US grant

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.